Form 990 for tax year 2024
Filed by LOVELACE BIOMEDICAL RESEARCH INSTITUTE.
Totals
- Total revenue
- $83,397,041
- Total expenses
- $87,744,696
- Contributions and grants received
- $12,194,618
- Grants paid
- $0
- Program service revenue
- $63,041,316
- Investment income
- $5,409,527
- Other revenue
- $2,751,580
- Total assets, end of year
- $255,478,512
- Total liabilities, end of year
- $48,316,899
- Net assets or fund balances, end of year
- $207,161,613
- Program services expenses (Part IX)
- $77,084,856
- Management and general expenses
- $10,659,840
- Fundraising expenses
- $0
- Program service expenses (Part III)
- $77,084,856
Program services were 87.9% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1d · Related organizations
$2,782,801
-
1e · Government grants (contributions)
$9,294,265
-
1f · All other contributions, gifts and grants
$117,552
-
2a · Program service revenue: BIOMEDICAL RESEARCH
total $50,746,173 · related or exempt $50,746,173
-
2b · Program service revenue: PROGRAM SERVICE CHARGE
total $12,295,143 · related or exempt $12,295,143
-
3 · Investment income
total $1,469,490 · excluded $1,469,490
-
5 · Royalties
total $32,278 · excluded $32,278
-
6a · Gross rents
real property $308,862
-
6b · Less rental expenses
real property $24,510
-
6c · Rental income or loss
real property $284,352
-
6d · Net rental income or loss
total $284,352 · excluded $284,352
-
7a · Gross sales of assets other than inventory
securities $43,458,349 · other assets $2,092
-
7b · Less cost or other basis and sales expenses
securities $39,520,404 · other assets $0
-
7c · Gain or loss
securities $3,937,945 · other assets $2,092
-
7d · Net gain or loss
total $3,940,037 · excluded $3,940,037
-
11a · Other revenue: INSURANCE CLAIM
total $2,394,950 · excluded $2,394,950
-
11d · All other revenue
total $40,000 · excluded $40,000
-
11e · Other revenue, total
$2,434,950
Functional expenses
Part IX, the statement of functional expenses.
-
5 · Compensation of officers, directors and key employees
total $1,718,514 · management and general $1,718,514
-
7 · Other salaries and wages
total $25,739,405 · program services $22,337,201 · management and general $3,402,204
-
8 · Pension plan contributions
total $2,304,702 · program services $2,000,069 · management and general $304,633
-
9 · Other employee benefits
total $6,790,340 · program services $5,934,757 · management and general $855,583
-
10 · Payroll taxes
total $2,169,951 · program services $1,883,129 · management and general $286,822
-
11b · Fees: legal
total $29,439 · management and general $29,439
-
11c · Fees: accounting
total $280,265 · management and general $280,265
-
11d · Fees: lobbying
total $76,802 · management and general $76,802
-
11f · Fees: investment management
total $105,958 · management and general $105,958
-
11g · Fees: other
total $6,842,617 · program services $6,270,804 · management and general $571,813
-
12 · Advertising and promotion
total $70,495 · program services $70,495
-
13 · Office expenses
total $316,061 · program services $295,206 · management and general $20,855
-
14 · Information technology
total $1,622,893 · program services $1,475,429 · management and general $147,464
-
16 · Occupancy
total $3,634,153 · program services $3,394,371 · management and general $239,782
-
17 · Travel
total $2,184,392 · program services $1,572,534 · management and general $611,858
-
19 · Conferences, conventions and meetings
total $160,505 · program services $140,901 · management and general $19,604
-
20 · Interest
total $835,869 · management and general $835,869
-
22 · Depreciation, depletion and amortization
total $7,600,442 · program services $6,765,141 · management and general $835,301
-
23 · Insurance
total $1,325,593 · program services $1,212,558 · management and general $113,035
-
24a · Other expenses: RESEARCH SUPPLIES
total $19,725,576 · program services $19,681,149 · management and general $44,427
-
24b · Other expenses: REPAIRS AND MAINTENANCE
total $1,610,166 · program services $1,503,927 · management and general $106,239
-
24c · Other expenses: NON-CAPITAL EQUIPMENT
total $810,674 · program services $757,301 · management and general $53,373
-
24e · All other expenses
total $1,789,884 · program services $1,789,884
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $19,224 · end of year $2,531
-
2 · Savings and temporary cash investments
beginning of year $446,470 · end of year $176,700
-
4 · Accounts receivable
beginning of year $25,772,876 · end of year $21,803,070
-
9 · Prepaid expenses and deferred charges
beginning of year $1,546,639 · end of year $1,606,510
-
10a · Land, buildings and equipment: cost or other basis
$144,383,049
-
10b · Land, buildings and equipment: accumulated depreciation
$12,601,566
-
10c · Land, buildings and equipment, net
beginning of year $110,795,643 · end of year $131,781,483
-
11 · Investments: publicly traded securities
beginning of year $66,109,196 · end of year $53,251,483
-
12 · Investments: other securities
beginning of year $4,233,737 · end of year $2,593,627
-
14 · Intangible assets
beginning of year $40,959,091 · end of year $38,138,636
-
15 · Other assets
beginning of year $6,538,156 · end of year $6,124,472
-
17 · Accounts payable and accrued expenses
beginning of year $11,756,698 · end of year $9,898,461
-
19 · Deferred revenue
beginning of year $15,621,944 · end of year $12,494,230
-
23 · Secured mortgages and notes payable
beginning of year $12,330,736 · end of year $9,991,412
-
25 · Other liabilities
beginning of year $4,688,810 · end of year $15,932,796
-
27 · Net assets without donor restrictions
beginning of year $212,022,844 · end of year $207,161,613
Mission and programs · 2024
Mission
THE LOVELACE BIOMEDICAL RESEARCH INSTITUTE (LBRI) IS A PRIVATE, BIOMEDICAL RESEARCH ORGANIZATION DEDICATED TO IMPROVING PUBLIC HEALTH THROUGH RESEARCH ON THE PREVENTION, DIAGNOSIS, TREATMENT AND CURE OF DISEASES. LBRI IS DEDICATED TO THE DISCOVERY AND ADVANCEMENT OF CLINICAL SOLUTIONS FOR PREVENTION, DIAGNOSIS, TREATMENT AND CURING DISEASES THROUGH RESEARCH. THE RESEARCH IS AIMED AT UNDERSTANDING THEIR CAUSES AND BIOLOGICAL MECHANISMS; ASSESSING AND ELIMINATING EXPOSURES TO RESPIRATORY, NEUROLOGICAL AND OTHER HEALTH HAZARDS; MENTAL ILLNESS; TRAUMATIC BRAIN INJURY AND OTHER BRAIN DISORDERS; AND DEVELOPING IMPROVED THERAPEUTICS, VACCINES, AND DIAGNOSTICS. LBRI IS BASED IN ALBUQUERQUE, NEW MEXICO.
Activities or mission (Part I)
THE LOVELACE BIOMEDICAL RESEARCH INSTITUTE (LBRI) IS A PRIVATE, BIOMEDICAL RESEARCH ORGANIZATION DEDICATED TO IMPROVING PUBLIC HEALTH THROUGH RESEARCH ON THE PREVENTION, TREATMENT AND CURE OF DISEASES. LBRI IS COMMITTED TO CURING DISEASES THROUGH RESEARCH AIMED AT UNDERSTANDING THEIR CAUSES AND BIOLOGICAL MECHANISMS; ASSESSING AND ELIMINATING EXPOSURES TO RESPIRATORY, NEUROLOGICAL AND OTHER HEALTH HAZARDS; AND DEVELOPING IMPROVED THERAPEUTICS, VACCINES, AND DIAGNOSTICS. LBRI IS BASED IN ALBUQUERQUE, NEW MEXICO.
-
MEDICAL RESEARCH AND EDUCATIONAL ACTIVITY IN THE AREAS OF BASIC BIOMEDICAL RESEARCH, HEALTH AND POPULATION STUDIES, INCLUDING RESPIRATORY DISEASES SUCH AS ASTHMA, COPD, ALLERGY AND TOXIC EFFECTS OF ENVIRONMENTAL FACTORS. ADDITIONAL AREAS INCLUDE NEUROLOGIC CONDITIONS SUCH AS TRAUMATIC BRAIN INJURY, ADDICTION AND PSYCHOPATHY.
Expenses $77,084,856 · Revenue $63,041,316
As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
Alan KadishALAN KADISH
PRESIDENT AND CHAIRMAN OF THE BOARD
- Total calculated
- $1,387,128
- From this org
- $0
- From related orgs
- $1,265,315
- Other
- $121,813
- Hours/week
- 2 + 40 related
Schedule J breakdown matched by us
- Base
- $0 + $1,097,945 related
- Bonus
- $0
- Other
- $0 + $167,370 related
- Deferred
- $0 + $97,250 related
- Nontaxable benefits
- $0 + $24,563 related
- Filer's total
- $0 + $1,387,128 related
-
Matthew F BonillaMATTHEW F BONILLA
SPECIAL APPOINTEE
- Total calculated
- $380,864
- From this org
- $0
- From related orgs
- $333,033
- Other
- $47,831
- Hours/week
- 2 + 40 related
Schedule J breakdown matched by us
- Base
- $0 + $333,033 related
- Bonus
- $0
- Other
- $0
- Deferred
- $0 + $17,250 related
- Nontaxable benefits
- $0 + $30,581 related
- Filer's total
- $0 + $380,864 related
-
Jane DelgadoJANE DELGADO
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Wanda HernandezWANDA HERNANDEZ
SPECIAL APPOINTEE (THRU 9/23/24)
- Total calculated
- $0
- Hours/week
- 2 + 40 related
-
Nicholas S JanigaNICHOLAS S JANIGA
SPECIAL APPOINTEE
- Total calculated
- $426,623
- From this org
- $0
- From related orgs
- $355,397
- Other
- $71,226
- Hours/week
- 2 + 40 related
Schedule J breakdown matched by us
- Base
- $0 + $355,397 related
- Bonus
- $0
- Other
- $0
- Deferred
- $0 + $32,480 related
- Nontaxable benefits
- $0 + $38,746 related
- Filer's total
- $0 + $426,623 related
-
Jackie Lovelace JohnsonJACKIE LOVELACE JOHNSON
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Jospeh D MarkJOSPEH D MARK
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Charles MattielloCHARLES MATTIELLO
SPECIAL APPOINTEE
- Total calculated
- $258,618
- From this org
- $0
- From related orgs
- $233,171
- Other
- $25,447
- Hours/week
- 2 + 40 related
Schedule J breakdown matched by us
- Base
- $0 + $233,171 related
- Bonus
- $0
- Other
- $0
- Deferred
- $0 + $11,701 related
- Nontaxable benefits
- $0 + $13,746 related
- Filer's total
- $0 + $258,618 related
-
Lawrence D PlattLAWRENCE D PLATT
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Margaret RetterMARGARET RETTER
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Zvigmond RyzmanZVIGMOND RYZMAN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Shannon L TomaSHANNON L TOMA
EXEC VP, COO, CFO
- Total calculated
- $770,069
- From this org
- $705,999
- From related orgs
- $0
- Other
- $64,070
- Hours/week
- 40 + 0.5 related
Schedule J breakdown matched by us
- Base
- $665,999
- Bonus
- $40,000
- Other
- $0
- Deferred
- $56,381
- Nontaxable benefits
- $7,689
- Filer's total
- $770,069
-
Robert W Rubin PhDROBERT W RUBIN PHD
CEO (THROUGH 5/31/25)
- Total calculated
- $845,514
- From this org
- $782,222
- From related orgs
- $0
- Other
- $63,292
- Hours/week
- 38 + 0.5 related
Schedule J breakdown matched by us
- Base
- $742,222
- Bonus
- $40,000
- Other
- $0
- Deferred
- $56,381
- Nontaxable benefits
- $6,911
- Filer's total
- $845,514
-
Salomon AmarSALOMON AMAR
CEO (STARTING 6/1/25)
- Total calculated
- $712,816
- From this org
- $0
- From related orgs
- $641,578
- Other
- $71,238
- Hours/week
- 38 + 0.5 related
Schedule J breakdown matched by us
- Base
- $0 + $584,008 related
- Bonus
- $0
- Other
- $0 + $57,570 related
- Deferred
- $0 + $33,950 related
- Nontaxable benefits
- $0 + $37,288 related
- Filer's total
- $0 + $712,816 related
-
Steven A BelinskySTEVEN A BELINSKY
VP, ACADEMIC RESEARCH/SR SCIENTIST
- Total calculated
- $435,984
- From this org
- $395,524
- From related orgs
- $0
- Other
- $40,460
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $363,524
- Bonus
- $32,000
- Other
- $0
- Deferred
- $33,881
- Nontaxable benefits
- $6,579
- Filer's total
- $435,984
-
Phillip KuehlPHILLIP KUEHL
SR. DIR., PRECLINICAL DRUG DEVELOPMENT
- Total calculated
- $328,637
- From this org
- $296,621
- From related orgs
- $0
- Other
- $32,016
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $276,621
- Bonus
- $20,000
- Other
- $0
- Deferred
- $31,382
- Nontaxable benefits
- $634
- Filer's total
- $328,637
-
Melanie Doyle-EiseleMELANIE DOYLE-EISELE
SR. DIRECTOR OF LIFE SCIENCES
- Total calculated
- $334,422
- From this org
- $295,478
- From related orgs
- $0
- Other
- $38,944
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $275,478
- Bonus
- $20,000
- Other
- $0
- Deferred
- $31,382
- Nontaxable benefits
- $7,562
- Filer's total
- $334,422
-
David M FlandersDAVID M FLANDERS
VP, HUMAN RESOURCES
- Total calculated
- $323,781
- From this org
- $289,027
- From related orgs
- $0
- Other
- $34,754
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $257,027
- Bonus
- $32,000
- Other
- $0
- Deferred
- $30,733
- Nontaxable benefits
- $4,021
- Filer's total
- $323,781
-
Kent KiehlKENT KIEHL
EXECUTIVE SCIENCE OFFICER
- Total calculated
- $375,938
- From this org
- $334,368
- From related orgs
- $0
- Other
- $41,570
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $334,368
- Bonus
- $0
- Other
- $0
- Deferred
- $33,881
- Nontaxable benefits
- $7,689
- Filer's total
- $375,938
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 3 · Compensation survey or study
- 3 · Approval by the board or compensation committee
- 7 · Other non-fixed payments
Answered no
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 8 · Paid under the initial-contract exception
The filer's explanations (Part III)
- PART I, LINE 7
- BONUSES ARE BASED ON TITLE AND ESTABLISHED BY THE BOARD OF DIRECTORS.
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
No itemized grants to organizations on this return.
Related organizations on this return
Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.
-
501(C)(3) · EDUCATION · NY
-
501(C)(3) · SUPPORTING ORGANIZATION TO UNIVERSITY · DE
Directly controlled by TOURO UNIVERSITY
-
501(C)(3) · EDUCATION · CA
Directly controlled by TOURO UNIVERSITY
-
TOURO UNIVERSITY NEVADA
501(C)(3) · EDUCATION · NV
Directly controlled by TOURO UNIVERSITY
-
TOURO COLLEGE AND UNIVERSITY SYSTEM INC
501(C)(3) · EDUCATION · NJ
Directly controlled by TOURO UNIVERSITY
-
501(C)(3) · EDUCATION · NY
Directly controlled by TOURO UNIVERSITY
-
RABBI DOV REVEL YESHIVA OF FOREST HILLS
501(C)(3) · EDUCATION · NY
Directly controlled by TOURO UNIVERSITY
-
TOURO LAW CENTER DEVELOPMENT FOUNDATION
501(C)(3) · SUPPORTING ORGANIZATION · NY
Directly controlled by TOURO UNIVERSITY
-
501(C)(3) · EDUCATION · NY
Directly controlled by TOURO UNIVERSITY
-
PARTNERSHIP FOR A HEALTHY POPULATION
501(C)(3) · HEALTH STUDY · NY
Directly controlled by TOURO UNIVERSITY
-
TOURO COLLEGE BERLIN
EDUCATION · GM
Directly controlled by TOURO UNIVERSITY
-
501(C)(3) · EDUCATION · IL
Directly controlled by TOURO UNIVERSITY
-
CONGREGATION BAIS DAVID
501(C)(3) · RELIGIOUS · NY
Directly controlled by TOURO UNIVERSITY
-
THE BIOTECHNOLOGY INCUBATOR AT NYMY INC
501(C)(3) · RESEARCH · NY
Directly controlled by NEW YORK MEDICAL COLLEGE
-
TOURO UNIVERSITY MEDICAL GROUP
501(C)(3) · HEALH CARE · CA
Directly controlled by TOURO UNIVERSITY CALIFORNIA
-
NYMC-SCHOOL OF MEDICINE FACULTY PRACTICE
501(C)(3) · HEALTH CARE · NY
Directly controlled by NEW YORK MEDICAL COLLEGE
-
BARBARA AND WILLIAM ROSENTHAL FDN
501(C)(3) · GRANTMAKING · NY
Directly controlled by NEW YORK MEDICAL COLLEGE
Taxable family on this return
Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.
Related corporations and trusts
Part IV: related organizations taxable as a corporation or trust.
-
LOVELACE SCIENTIFIC RESOURCES
C · CLINICAL TRIAL REASEARCH · NM · 100% owned · share of income $50,877 · share of assets $5,000 · controlled entity
Directly controlled by LOVELACE BIOMEDICAL RESEARCH INSTITUTE
-
TOURO SPEECH AND HEARING CLINIC INC
C · INACTIVE · NY
-
TOURO FOUNDATION CORPORATION
C · INACTIVE · NY
-
TOURO UNIVERSITY FOUNDATION
C · INACTIVE · NY
-
TOURO COLLEGE FOUNDATION FOR JEWISH STUDIES
C · INACTIVE · NY
-
TOURO UNIVERSITY MEDICAL ASSOCIATES
C · HEALTH CARE · CA
-
TOURO COLLEGE OF DENTAL MEDICINE FACULTY PRACTICE CORPORATION
C · HEALTH CARE · NY
-
SPEECH LANGUAGE PATHOLOGY PC
C · HEALTH CARE · NY
Provenance
- Return type
- form_990
- Tax year
- 2024
- Filed
- 12 May 2026
- IRS schema version
- 2024v5.5
- Source object
- 202611349349304466
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.